Inoviq Ltd (AU:IIQ) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Inoviq Ltd has announced a breakthrough in ovarian cancer testing, with its EXO-OC blood test achieving over 94% accuracy in independent patient validation. This promising development could revolutionize early-stage ovarian cancer detection, crucially improving patient outcomes and survival rates. The company plans to optimize the test for commercial use and further clinical validation.
For further insights into AU:IIQ stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue